Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 15/20 | 1.00 |
| ▸ | ERAP1 | Q9NZ08 | 14/20 | 1.00 |
| ▸ | ERAP2 | Q6P179 | 13/20 | 1.00 |
| ▸ | LAP3 | P28838 | 4/20 | 1.00 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.88 |
| ▸ | IL1RN | P18510 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21067570 | 1.00 | ANPEP (1.00) | ANPEPERAP1ERAP2LAP3ENPEP | |
| SCHEMBL9646484 | 0.82 | ERAP1 (0.70) | ANPEPERAP1ERAP2LAP3ENPEP | |
| SCHEMBL9696151 | 0.81 | ANPEP (0.72) | ANPEPERAP1ERAP2LAP3ENPEP | |
| SCHEMBL29371424 | 0.79 | ERAP2 (1.00) | ANPEPERAP1ERAP2LAP3IL1RN | |
| SCHEMBL9697346 | 0.79 | ERAP1 (0.65) | ANPEPERAP1ERAP2LAP3ENPEP | |
| SCHEMBL10958332 | 0.78 | ERAP1 (0.68) | ANPEPERAP1ERAP2LAP3ENPEP | |
| SCHEMBL9647855 | 0.77 | ERAP2 (0.63) | ANPEPERAP1ERAP2LAP3ENPEP | |
| SCHEMBL5059848 | 0.77 | FOLH1 (0.69) | ANPEPERAP1ERAP2LAP3 | |
| SCHEMBL1859177 | 0.77 | CYP1A2 (0.73) | ANPEPERAP1ERAP2LAP3 | |
| SCHEMBL6518228 | 0.75 | ANPEP (1.00) | ANPEPERAP1ERAP2LAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |